fbpx

List – 44 Drug Patents that are Expiring in 2029

Table of Contents

[vc_row][vc_column][vc_column_text css=”.vc_custom_1655539952615{margin-bottom: 0px !important;}”]Last week we uncovered the list of drug patents expiring in 2028. But can highfliers like you and I stop at that?

Well, rest your numbing tendons for we’re here with the list of drug patents expiring in 2029. The list includes not just the drug names but also other information like yearly sales, treatment, ingredients, and the disease they cure which could help them (you) easily choose the drug most profitable to develop a generic version.

Without any delay, here is the list of drugs. Thank us later!

The article has a list of drug patents expiring in 2029. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below.


[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Drug Patents Expiring in 2029[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Lamictal Odt
Lamotrigine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7919115 January 4, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653373041039{margin-bottom: 0px !important;}”]Dosage: Oral
Company: GlaxoSmithKline
Ingredients: LAMOTRIGINE
Treatment: Epilepsy[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Wakix
Pitolisant[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8207197 February 25, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653388925484{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Harmony Biosciences Llc
Ingredients: PITOLISANT HYDROCHLORIDE
Treatment: Excessive Daytime Sleepiness[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Caplyta
Lumateperone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US9586960 March 12, 2029
USRE48825 March 12, 2029
US8648077 December 1, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653388996444{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Intra-cellular Therapies Inc
Ingredients: LUMATEPERONE TOSYLATE
Treatment: Schizophrenia And Bipolar Depression[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Desyrel
Trazodone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8133893 March 13, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389061834{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pragma Pharmaceuticals Llc
Ingredients: TRAZODONE HYDROCHLORIDE
Treatment: Major Depressive Disorder, Anxiety Disorders, and Difficulties With Sleep[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Neuraceq
Florbetaben[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7807135 March 18, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389124092{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Life Molecular Imaging Ltd
Ingredients: FLORBETABEN F-18
Treatment: Alzheimer’s Disease[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Monoferric
Ferric derisomaltose[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US10414831 March 25, 2029
US8815301 August 14, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389190127{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Pharmacosmos As
Ingredients: FERRIC DERISOMALTOSE
Treatment: Iron Deficiency Anemia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Gemtesa
Vibegron[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8653260 April 2, 2029
US8247415 December 1, 2030

[/mk_table][vc_column_text css=”.vc_custom_1653389252852{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Urovant Sciences Gmbh
Ingredients: VIBEGRON
Treatment: Overactive Bladder[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Kerendia
Finerenone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8436180 April 12, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389328068{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: FINERENONE
Treatment: Kidney Function[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Triferic
Ferric Pyrophosphate Citrate[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7816404 April 17, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389384604{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Rockwell Medical Inc
Ingredients: FERRIC PYROPHOSPHATE CITRATE
Treatment: Iron Deficiency Anemia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Cipro
Ciprofloxacine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US9603796 April 21, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389450683{margin-bottom: 0px !important;}”]Dosage: Oral, Intravenous, Topical
Company: Alk-abello Inc
Ingredients: CIPROFLOXACIN
Treatment: Bacterial Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Veklury
Remdesivir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
USRE46762 April 22, 2029
US8318682 April 22, 2029
US8008264 September 6, 2029
US10065958 September 16, 2031
US9724360 October 29, 2035
US9949994 October 29, 2035

[/mk_table][vc_column_text css=”.vc_custom_1653389557460{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Gilead Sciences Inc
Ingredients: REMDESIVIR
Treatment: Antiviral[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zejula
Niraparib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8436185 April 24, 2029
US8071623 March 27, 2031

[/mk_table][vc_column_text css=”.vc_custom_1653389638547{margin-bottom: 0px !important;}”]Dosage: Oral
Company: GlaxoSmithKline Llc
Ingredients: NIRAPARIB TOSYLATE
Treatment: Anti-cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zeposia
Ozanimod[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8481573 May 14, 2029
US8796318 May 14, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389700021{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Celgene International Ii Sarl
Ingredients: OZANIMOD HYDROCHLORIDE
Treatment: Multiple Sclerosis And Ulcerative Colitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tauvid
Flortaucipir (18F)[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8932557 May 19, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389764846{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Avid Radiopharmaceuticals Inc
Ingredients: FLORTAUCIPIR F-18
Treatment: Radioactive Diagnostic Agent[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Opana Er
Oxymorphone[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7851482 July 10, 2029
US8871779 November 22, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653389837154{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Endo Pharmaceuticals Inc
Ingredients: OXYMORPHONE HYDROCHLORIDE
Treatment: Severe Pain[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Braftovi
Encorafenib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8946250 July 23, 2029
US8541575 February 26, 2030
US9593099 August 27, 2030
US8501758 March 4, 2031

[/mk_table][vc_column_text css=”.vc_custom_1653389926350{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Array Biopharma Inc
Ingredients: ENCORAFENIB
Treatment: Melanoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Odomzo
Sonidegib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8178563 July 24, 2029
US8063043 September 15, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653390013781{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Sun Pharmaceutical Industries Ltd
Ingredients: SONIDEGIB PHOSPHATE
Treatment: Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zepatier
Elbasvir/Grazoprevir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7973040 July 24, 2029
US8871759 May 4, 2031

[/mk_table][vc_column_text css=”.vc_custom_1653390155119{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Merck Sharp And Dohme Corp
Ingredients: ELBASVIR; GRAZOPREVIR
Treatment: Hepatitis C[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row]

[vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Talzenna
Talazoparib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8420650 July 27, 2029
US8012976 October 19, 2029
US10189837 October 20, 2031
US8735392 October 20, 2031

[/mk_table][vc_column_text css=”.vc_custom_1653390239597{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pfizer Inc
Ingredients: TALAZOPARIB TOSYLATE
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Evotaz
Atazanavir/Cobicistat[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8148374 September 3, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653390355476{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bristol-Myers Squibb Co
Ingredients: ATAZANAVIR SULFATE; COBICISTAT
Treatment: HIV/AIDS[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Piqray
Alpelisib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8476268 September 10, 2029
US8227462 September 28, 2030

[/mk_table][vc_column_text css=”.vc_custom_1653390423702{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: ALPELISIB
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tykerb
Lapatinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8821927 September 18, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653390522854{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: LAPATINIB DITOSYLATE
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Treanda
Bendamustine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8445524 September 26, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653390589760{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Cephalon Inc
Ingredients: BENDAMUSTINE HYDROCHLORIDE
Treatment: Chronic Lymphocytic Leukemia, Multiple Myeloma, And Non-Hodgkin’s Lymphoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Ingrezza
Valbenazine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8039627 October 6, 2029
US10065952 October 28, 2036
US10844058 October 28, 2036
US10851103 October 28, 2036
US10851104 October 28, 2036
US10906902 December 22, 2036
US10919892 December 22, 2036
US10906903 December 22, 2036

[/mk_table][vc_column_text css=”.vc_custom_1653390726015{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Neurocrine Biosciences Inc
Ingredients: VALBENAZINE TOSYLATE
Treatment: Tardive Dyskinesia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vitrakvi
Larotrectinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US9127013 October 21, 2029
US8513263 December 23, 2029
US10172861 November 16, 2035
US10799505 August 15, 2036

[/mk_table][vc_column_text css=”.vc_custom_1653390844494{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: LAROTRECTINIB SULFATE
Treatment: Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Rezurock
Belumosudil[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8357693 October 30, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653390955200{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Kadmon Pharmaceuticals Llc
Ingredients: BELUMOSUDIL MESYLATE
Treatment: Chronic Graft Versus Host Disease[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Cotellic
Cobimetinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7803839 November 10, 2029
US10478400 June 29, 2036/td>
US10590102 June 30, 2036

[/mk_table][vc_column_text css=”.vc_custom_1653391045986{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genentech Inc
Ingredients: COBIMETINIB FUMARATE
Treatment: Anti-cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Recarbrio
Imipenem/Cilastatin/Relebactam[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8487093 November 19, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653391130102{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Merck Sharp And Dohme 
Ingredients: CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
Treatment: Urinary Tract And Complicated Intra-abdominal Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Belsomra
Suvorexant[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7951797 November 20, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653391192178{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Merck Sharp And Dohme 
Ingredients: SUVOREXANT
Treatment: Insomnia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Verzenio
Abemaciclib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US7855211 December 15, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653391245916{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Eli Lilly And Co
Ingredients: ABEMACICLIB
Treatment: Breast Cancers[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tavneos
Avacopan[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8906938 December 21, 2029
US8445515 February 3, 2031

[/mk_table][vc_column_text css=”.vc_custom_1653391318625{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Chemocentryx Inc
Ingredients: AVACOPAN
Treatment: Anti-neutrophil Cytoplasmic Auto antibody-associated Vasculitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Ibsrela
Tenapanor[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8541448 December 30, 2029
US8969377 December 30, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653391471847{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Ardelyx Inc
Ingredients: TENAPANOR HYDROCHLORIDE
Treatment: Irritable Bowel Syndrome[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Eucrisa
Crisaborole[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]

Patents Expiration Date
US8039451 December 29, 2029

[/mk_table][vc_column_text css=”.vc_custom_1653391397087{margin-bottom: 0px !important;}”]Dosage: Topical
Company: Anacor Pharmaceuticals Inc
Ingredients: CRISABOROLE
Treatment: Atopic Dermatitis[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1655540702015{margin-bottom: 0px !important;}”]With the huge growth in the generic drug market, it has become essential for generic companies like yours to keep a tab on the drugs with a soon-to-be-expired label. But that’s not enough, you have to stay ahead of your competitors too. This is where GreyB comes in!

Our pharma team is working on its toes to extract all the drug patents expiring in the next 8 years from now. Want to get your hands on the complete list?[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row]

Share This Article:

Meet The Authors

Related Articles

More Curated Insights For You

Facing A Roadblock On Your Project?

Our Experts Are Here To Help.